Sartorius Stedim Biotech Gross Profit Growth & History (DIM)
Sartorius Stedim Biotech's gross profit was €1.35B for fiscal 2025.
View full Sartorius Stedim Biotech company overviewSartorius Stedim Biotech annual gross profit history
2020
2021
2022
2023
2024
2025
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €1.35B | €138.6M | +11.49% |
| 2024 | 2024-12-31 | €1.21B | −€27.3M | −2.21% |
| 2023 | 2023-12-31 | €1.23B | −€583.4M | −32.10% |
| 2022 | 2022-12-31 | €1.82B | €264.4M | +17.03% |
| 2021 | 2021-12-31 | €1.55B | €549.7M | +54.79% |
| 2020 | 2020-12-31 | €1.00B | — | — |
Sartorius Stedim Biotech gross profit trends
Over the last five fiscal years, Sartorius Stedim Biotech's gross profit increased from €1.00B to €1.35B, a change of €342.0M.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
reported and calculated gross profit
TickerStat uses gross profit reported in company official filings when available. Otherwise, it calculates gross profit as reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sartorius Stedim Biotech source filings ↗